|
Price: $33.2500
$0.16 
0.484%
|
| Day's High:
| $33.5127
| Week Perf:
| -4.29 %
|
| Day's Low: |
$ 32.89 |
30 Day Perf: |
-8.28 % |
| Volume (M): |
548 |
52 Wk High: |
$ 45.98 |
| Volume (M$): |
$ 18,234 |
52 Wk Avg: |
$35.83 |
| Open: |
$32.99 |
52 Wk Low: |
$28.03 |
|
|
| Market Capitalization (Millions $) |
3,345 |
| Shares
Outstanding (Millions) |
101 |
| Employees |
201 |
| Revenues (TTM) (Millions $) |
957 |
| Net Income (TTM) (Millions $) |
49 |
| Cash Flow (TTM) (Millions $) |
116 |
| Capital Exp. (TTM) (Millions $) |
4 |
Progyny Inc
Progyny Inc is a leading provider of employer-sponsored fertility benefits and care.
The company provides comprehensive fertility solutions to self-insured employers, large enterprises, and employees, addressing the broad range of needs individuals face when seeking fertility care.
It uses advanced technology and data analytics to provide personalized care plans and cost-effective, evidence-based treatments.
Progyny's mission is to provide support, education, and assistance to individuals struggling to achieve their dream of starting a family.
Its emphasis on personalized care plans and proactive guidance sets it apart from traditional fertility benefits providers.
The company has developed strong partnerships with top-tier fertility clinics, enabling it to offer the latest and most advanced treatments to its patients.
With a robust portfolio of services, Progyny offers a full suite of fertility benefits, including fertility assessments, FDA-approved medications, egg freezing, in-vitro fertilization (IVF), genetic testing, and surrogacy services.
Its proprietary platform, called "PURE," provides members with easy access to patient-centric care and support services, including telemedicine consultations with fertility specialists, virtual support groups, and personalized health coaching.
Progyny's innovative approach to fertility care has earned it several accolades, including being named one of the "50 Smartest Companies" by MIT Technology Review and one of the "Most Innovative Companies" in healthcare by Fast Company.
The company has also been recognized for its emphasis on employee well-being, earning multiple awards and recognition for being a great place to work.
Overall, Progyny Inc is a rapidly-growing company that's reshaping the fertility benefits industry by providing a comprehensive suite of personalized care services to individuals seeking to start families.
Its focus on innovative technology, a broad network of high-quality clinics, and a patient-centric approach provides members with the support and resources they need to achieve their fertility goals.
Company Address: 1359 Broadway New York 10018 NY
Company Phone Number: 888-3124 Stock Exchange / Ticker: NASDAQ PGNY
| PGNY is expected to report next financial results on November 03, 2023. |
|
|
|
|
|
|
|
|
| Stock Performances by Major Competitors |
|
|
|
|
Jrsis Health Care Corporation
The stock market is constantly influenced by a variety of factors, including company financial reports. Recently, Jrsis Health Care Corporation disclosed its revenue and net shortfall figures for the financial second quarter of 2023, presenting an interesting outlook for investors. Amidst a challenging market environment, Jrsis Health Care Corporation showcased some positive developments and potential growth opportunities.
Revenue and Net Shortfall:
Jrsis Health Care Corporation reported a remarkable revenue of $0.043317 million for the financial second quarter of 2023. This indicates a promising upward trend for the company, especially when compared to the corresponding reporting period from a year ago.
|
|
Imac Holdings Inc
The stock market can often be unpredictable, but there are always opportunities for those who pay close attention to the numbers. In the fiscal span of April to June 2023, BACK, a leading company in the Healthcare Facilities industry, decreased its loss per share to $-0.04, compared to $-0.07 the previous year. This improvement in earnings per share shows promising growth for the company.
Moreover, BACK's revenue experienced a sharp decline of -73.297% to $1.34 million from $5.03 million in the previous comparable financial reporting period. Although this might seem concerning, it is essential to consider the context. Many companies in the Healthcare Facilities industry also faced revenue decreases during this period. However, it is worth noting that BACK saw a sequential revenue tumble of only -35.798% from $2.09 million, indicating some stability and potential for recovery.
|
|
Ethema Health Corporation
Introduction
Ethema Health Corporation n has released its most recent fiscal period results, showcasing its ability to weather the storm within the stock market. While the company reported balanced books per share, notable increases were witnessed in both revenue and net deficit. In this article, we will delve into these facts and analyze how Ethema Health Corporation has outperformed its peers within the Healthcare Facilities sector.
Revenue Growth Surges
One of the most impressive feats achieved by Ethema Health Corporation is the significant jump in revenue. Comparing the most recent fiscal period to the same period a year ago, revenues soared by an impressive 37.602% to reach $1.57 million. This growth is even more remarkable since it outpaces the sector average of 7.67% during the same period. Sequentially, the company improved its revenue by 20.454% from $1.30 million, further highlighting its stability and upward trajectory.
|
|
Pacific Health Care Organization Inc
The stock market is an ever-evolving entity, driven by financial results and market sentiment. Today, we take a closer look at the Pacific Health Care Organization Inc (PHCO), analyzing the recently released financial reports for the interval ending June 30, 2023. The company's net profit per share remained unchanged compared to the previous year, while revenue saw a decrease. Despite a decline in operating earnings, the company made strides in improving its net margin. We delve deeper into these findings and their implications for PHCO.
Revenue Decline and Contrasting Sector Performance:
In the financial interval ending June 30, 2023, PHCO experienced a 7.252% decline in revenue, dropping from $1.40 million to $1.30 million when compared to the previous year. Sequentially, the revenue declined by 1.047% from $1.31 million. These figures indicate a slump in business for PHCO, unlike the overall Healthcare Facilities sector, which posted a revenue gain during the same period. This contrasting performance merits further examination and calls into question PHCO's market positioning and competitive landscape.
|
|
Brookdale Senior Living Inc
Brookdale Senior Living Inc, a prominent player in the Healthcare Facilities sector, recently released its financial results for the April to June 30, 2023, period. While the company reported a decrease in loss per share and an improvement in income per share, it faced a slight decline in sequential revenue. This article aims to interpret these financial results and analyze how they may impact Brookdale Senior Living Inc's future business prospects.
Decreased Loss per Share and Improved Income per Share:
One significant positive aspect of Brookdale Senior Living Inc's financial results was the decrease in loss per share compared to the same period last year. The company managed to reduce the loss per share from $-0.45 to $-0.02, indicating a significant improvement in its financial performance. Additionally, the income per share showed growth, increasing from $-0.20 to an undisclosed positive value. These improvements suggest that Brookdale Senior Living Inc is moving towards profitability and achieving financial stability.
|
| Per Share |
Current |
| Earnings (TTM) |
150.34 $ |
| Revenues (TTM) |
9.51 $
|
| Cash Flow (TTM) |
1.15 $ |
| Cash |
2.81 $
|
| Book Value |
4.67 $
|
| Dividend (TTM) |
0 $ |
|
|
| Per Share |
|
| Earnings (TTM) |
150.34 $
|
| Revenues (TTM) |
9.51 $ |
| Cash Flow (TTM) |
1.15 $ |
| Cash |
2.81 $
|
| Book Value |
4.67 $ |
| Dividend (TTM) |
0 $ |
|
|
|
|
